The immunogenicity and antigenicity of an enzymatically functional (ATPase/helicase) recombinant protein encompassing residues 1207-1612 of the hepatitis C virus (HCV) non-structural 3 (NS3) protein was characterized using B10 congenic mice. Previous studies have indicated a high frequency of NS3-specific antibodies in HCV-infected humans. Similarly, all six immunized murine haplotypes were antibody responders to the NS3 ATPase/helicase domain, with the H-2 k and H-2" haplotypes as high responders. As also observed in HCV-infected humans, the murine NS3 antibodies were predominantly directed to conformational determinants. Irrespective of the murine haplotype, IgG1 predominated in the primary anti-NS3 response, whereas IgG1 and IgG2b predominated in the secondary response. The antibody responder hierarchy was reiterated at the T cell level, with the H-2 k and the H-2' hapIotypes as the best responders. In both the H-2 d and H-2" hapIotypes ATPase/ helicase-primed T cells secreted interleukin 2 and interferon y, corroborating observations from HCVinfected humans. In the H-2 d, H-2 k and H-2' hapIotypes the fine specificity of the T cell recognition of the ATPase/helicase domain was further characterized. Multiple, although generally weak, T cell recognition sites were found for all three haplotypes. The large size of the NS3 protein together with the presence of multiple class II binding motifs explain the high prevalence of NS3 antibodies in immunized mice and predict a similar explanation for the observed high frequency of NS3-specific antibodies in HCV-infected humans.
Introduction
The non-structural 3 (NS3) protein of hepatitis C virus (HCV) has been found to have several different functions. The N-terminal third of NS3 contains a serine protease domain which, alone or together with NS4a, cleaves the precursor polyprotein downstream of the NS3-NS4a junction (Bartenschlager et a[., 1993; Grakoui et al., 1993a, b) . The C-terminal two thirds of the NS3 sequence has been found to contain domains for both ATPase and helicase activity (Jin et al., 1995) . Possibly owing to these vital enzymatic functions, the NS3 protein is one of the HCV proteins with the lowest sequence variability with respect to virus genotypes. Therefore NS3 Author for correspondence: Matti Sallberg.
Fax +46 8 746 59 69. e-mail masa@vird01 .hs.sll.se may be a valuable target for the design of both enzymatic and immunological therapeutics.
In the HCV-infected human host the NS3 protein seems to be fairly immunogenic. This is supported by several observations. First, a majority of patients with chronic HCV infection develop antibodies to NS3 (Lok et at., I993) . Secondly, early in the acute phase of infection NS3 antibodies appear to be the most prevalent, as determined by recombinant proteins . Thirdly, in vitro T cell activation in response to NS3, although generally weak, has been detected in a number of studies of patients with acute or chronic HCV infection Ferrari et al., 1994; Hoffmann et al., 1995) . It was recently proposed that a strong in vitro T cell reaction to NS3 correlated with clearance of acute HCV infection whereas a less vigorous, or absent, NS3-specific T cell reactivity was observed in those who progressed to chronicity -~72 . It appears somewhat inconsistent that despite a seemingly strong NS3-specific T cell activity in the acute phase, significant NS3 antibody responses do not develop until progression to chronicity when the T cell activity is low.
To characterize the immunogenicity and antigenicity of the ATPase/helicase domain of HCV NS3, we immunized inbred mice with an enzymatically functional recombinant protein.
We found that the recombinant NS3 protein is quite immunogenic in mice and some aspects of the murine immune response are similar to observations in HCV-infected humans with respect to both B and T cells.
Methods
• Mice. Inbred BIO mice, B10 (H-2b), BIO.D2 (H-2d), B10.M (H-2f), BIO.BR (H-2g), BIO.P (H-2 p) and BIO.S (H-2S), and BALB/c (H-2 b) and C3H/He (H-2 g) mice were obtained from either the breeding facility at The Scripps Research Institute or through BK Universal. All mice were used at 4-10 weeks of age.
• Recombinant NS3 ATPase/helicase domain protein. The expression, purification and enzymatic characterization of a recombinant HCV NS3 (rNS3) protein, genotype la, covering residues 1207-1612 has previously been described (Jin et aI., 1995) . Prior to use as a recall antigen in T cell cultures, rNS3 was dialysed against PBS overnight and sterilized by UV-irradiation for 20 min.
• Synthetic peptide analogues. The synthesis of overlapping peptides corresponding to the complete sequence of HCV NS3 of genotype la (Takamizawa et aL, 1991) has been described (Zhang et al., 1994) . Additional peptides were produced by a multiple peptide synthesizer (Syro MultiSynTech; Syntex) using Fmoc-protected amino acids. The peptides were cleaved and deprotected according to standard protocols for Fmoc peptide synthesis (S~illberg et aL, 1991) . The crude peptides were analysed by reversed phase HPLC using a PepS-5 C18 column (Pharmacia).
• ELISA. All ELISAs for the detection of murine anti-NS3 antibodies were essentially performed as described previously (Milich et al., 1987) . In brief, rNS3 was passively adsorbed at 0"4 ~tg/ml into 96-well microtitre plates in 50 raM-sodium carbonate buffer pH 9"6, overnight at 4 °C. Serial dilutions of sera were then incubated on the plates for 90 min. Bound routine serum antibodies were detected by either rabbit anti-mouse IgG (Sigma), or rabbit anti-mouse IgG1, IgG2a, IgG2b or IgG3 (Collaborative Biomedical) followed by a peroxidase-labelled goat anti-rabbit IgG (Boehringer Mannheim; Milich et aL, 1995) .
Analysis of reactivities to linear determinants was performed using the NS3-specific synthetic peptides coated onto microtitre plates at a concentration of 10 ,g/ml. The remainder of the assay was performed as described above.
• T cell proliferation and cytokine assays. Groups of three to five mice were injected with 50 ~,g of rNS3 emulsified in Freund's complete adjuvant either intraperitoneally (i.p.) or subcutaneously (s.c.) in the hind footpads or at the base of the tail. Nine to I1 days later the mice were sacrificed and the spIeens or draining lymph nodes were harvested. Single cell suspensions were prepared in Click's media and plated on microtitre plates at 6 x 10 s cells per well for proliferation assays and 8 x 10 ~ cells per well for cytokine assays. Supematants (100 ~I) were removed at 24 h for determination of interleukin 2 (IL-2) and at 48 h for determination of IL-4 and interferon y (IFN-7). The plates for T cell proliferation were incubated for 96 h with the addition of 1 ,Ci of [3H]thymidine (TdR; Amersham) for the last 16 h. The labelled cells were harvested onto cellulose filters, quenched and the level of [aH]TdR incorporation was determined by a liquid scintillation fl-counter.
The presence of cytokines was determined as previously described (Milich et al., I995) . In brief, the presence of IL-2 in supematants was determined by proliferation of the IL-2-sensitive NK'A cell line. The presence of IL-4 was determined by the IL-4-sensitive CT4.S cell line and the presence of IFN-y was determined by a sandwich ELBA (Milich et al., 1995) .
Results

Influence of MHC genes on murine immune recognition of the ATPase/helicase domain of NS3
Groups of three to six H-2 congenic BIO mice, haplotypes H-2 b, H-2 a, H-2 r, H-2 k, H-2 p and H-2 s, were primed and boosted (four weeks later) i.p. with 20 ,g of rNS3 in adjuvant. Within the six haplotypes two were high responders (H-2 k and H-2S), three were intermediate (H-2 b, H-2 a and H-2 p) and one was a low responder (H-2f; Fig. I ). This confirms the influence of the murine MHC genes on the ability to respond to rNS3. The serum antibody end-point titres were within the same range as those observed to the ATPase/helicase domain in HCV-positive human sera (titre range 1:2500 to 1:100000; Milich, unpublished results) . The primary NS3 response in the two high responder strains was restricted to IgG1, whereas the secondary response in all strains was predominantly IgG1 and IgG2b (Fig. 1) . In the H-26, H-2 u and H-2 s haplotypes 10-to 100-fold lower levels of IgG2a and/or IgG3 were also detected. The H-2 r haplotype showed the lowest total anti-NS3 IgG as well as the lowest IgG1 and IgG2b titres, which suggested a low responder status. Interestingly, the IgG isotype pattern of the primary response may have a counterpart in the human NS3-specific IgG subclass response, which is highly restricted (M. Chen, M.
Milich, unpublished results).
Specificity of the murine B cell response to the NS3 ATPase/helicase domain
In contrast to other HCV proteins such as the core and NS4 proteins, there is a less frequent and lower level of antibody reactivity to linear NS3 B cell determinants represented by synthetic peptides in most human sera (Khudyakov et al., 1995 ; S~illberg et al., 1992 Zhang et al., 1995) , This was also true in NS3 ATPase/helicase-immunized mice. Low level antibody reactivity to linear determinants was observed in the H-2 a and H-2 k haplotypes and less frequently or not at all in the other four haplotypes (Fig. 2 and data not shown). Reactivities to these regions are also rare in sera from HCVinfected patients (Khudyakov et al., 1995 ; Zhang et al., 1994) . Also, murine antibody titres to linear determinants were at least lO-foId lower compared to the rNS3 protein, confirming that the reactivity was predominantly directed against a T-----
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Specificity of the murine T cell response to the NS3 ATPase/helicase domain
When analysing in vivo-primed rNS3-specific T cells by in vitro recall, the antibody responder hierarchy was reiterated, with the H-2 k and H-2 s haplotypes as the high responders and a weaker response in the H-2 b and H-2 a haplotypes (Fig. 3 a) . The H-2 r and H-2 p haplotypes were not further evaluated at the T cell level• To characterize further the phenotype of polyclonal H-2 aand H-2k-restricted T cells specific for the NS3 ATPase/ helicase domain, groups of two to three mice (BALB/c and C3H/He) were primed with 50 gg of rNS3 in the hind footpads. The phenotypes of the polyclonal responses were analysed with respect to secretion of IL-2, IL-4 and IFN-> Irrespective of the H-2 haplotype, ATPase/helicase-primed T cells predominantly secreted IL-2 and IFN-7 into culture supernatants (Fig. 3 c, d ). Low levels of IL-4 could only be detected in the H-2 k supematants (Fig. 3 e) . Thus, the phenotypes of the polyclonal murine T cell responses to the ATPase/helicase domain of NS3 in the H-2 a and H-2 k haplotypes were Thl-or '-~ x Z~ 60 6-" h~ x. Th0-1ike. This is similar to reports of human NS3-specific T cell clones (Diepolder et aI., 1995) . The fine specificity and characteristics of the ATPase/ helicase-specific T cell response were studied in the H-2 a, H-2 k and H-2 s haplotypes. Mice were primed with 50 I~g of rNS3 in complete adjuvant given i.p. or in the hind footpads, and 9 to 11 days later spleens or draining lymph nodes were harvested and tested for in vitro recall responses using rNS3 and overlapping peptides. All three haplotypes recognized multiple determinants within the 400 amino acid sequence (Fig. 4 and data not shown). The approximate locations of H-2 a T cell recognition sites were at residues 1307-1322, 1367-1382 and 1597-1612; for H-2 k mice residues 1237-1252, 1387-1402, 1447-1462 and 1547-1562 were recognized, and for H-2 s mice 1217-1232, 1307-1322 and 1517-1532 were recognized (Fig. 4 and data not shown) . Given the length of this protein, the presence of multiple, although weak, MHC-restricted T cell recognition sites in high responder murine stains to NS3 is not unexpected. The ability of the four identified H-2k-restricted T cell sites to prime ATPase/helicase-specific T cells was analysed by priming groups of BI0.BR and C3H/He mice with 100 I~g of the respective peptide or with 25 I~g rNS3 as a control. The primed T cells were then analysed in vitro for the abiiity to be recalled by peptide or rNS3. All synthetic T celi sites were able to prime T cells which were recalled by recombinant ATPase/helicase protein in vitro and vice versa (Fig. 4 and data not shown) . This verifies that these sites are also generated through antigen-presenting cell processing of rNS3 as determined by both proliferation (Fig. 4 and data not shown) and cytokine production (data not shown) in vitro. However, in two cases (1237-1252 and 1547-1562) the peptide-primed T cells were more efficiently recalled by the immunogen itself than rNS3 (data not shown) suggesting that further analysis of N-and C-terminally truncated analogues of the respective regions is needed to define precisely the T cell site boundaries.
The identified approximate T cell sites in the H-2 k haplotype were further analysed with respect to genotypic sequence variability to determine whether the genotype of HCV NS3 might influence the response. Alignments of three out of the four T cell sites are listed in Table 1 . The fourth site at residues 1387-1402 did not show any variability within genotypes la, lb, 2a, 2b, 2e/f or 3a. All other sites showed a varying degree of genotypic sequence variability especially with respect to genotype 2 (Table 1) . Taken together this would suggest that genotype-specific and non-cross-reactive NS3-specific T cells may be elicited. However, using the H-2 k haplotype as an example, a non-responder status due to genotypic variations can be excluded since one site was completely conserved. This indicates that the HCV NS3 protein may also induce cross-reactive T cell responses in HCV-infected humans.
Discussion
Apart from the defined enzymatic functions of the HCV NS3 protein in the virus life-cycle little is known about the intrinsic immunogenicity and antigenicity of NS3 in HCVinfected humans. Most patients with chronic HCV infection develop antibodies to NS3 and some demonstrate detectable NS3-specific T cells in vitro (Ferrari et aI., 1994; Hoffmann et al., 1995; Iwata eta] ., 1995; Lok et a]., 1993). In contrast, HCVinfected patients with acute infection appear to have readily detectable NS3-specific T cells but less frequently produce NS3-specific antibodies (Diepolder e~ a] ., 1995). These observations suggest several possibilities. Either the HCV NS3 protein is an intrinsically poor immunogen in humans or the presence of NS3 antigen is low throughout the infection, thereby limiting NS3-specific immune responses. To investigate the immunogenicity of the ATPase/helicase domain of NS3 we immunized inbred mice of different haplotypes and analysed the humoral and cellular responses. We found that the level of the response to the NS3 ATPase/helicase domain was MHCdependent. However, none of the six haplotypes was found to be a non-responder to NS3. Moreover, the humoral responder status was dependent on the T cell responder status since both results correlated very well. In three haplotypes we observed multiple T cell recognition sites within NS3. In combination with the 400 plus amino acid length of the ATPase/helicase domain of NS3 this explains the high frequency of NS3 antibodies in mice. Most likely this is also true in humans since T cell non-responsiveness to NS3 in an outbred human population is even less likely. Thus, no data obtained in the murine model of the immunogenicity of the HCV NS3 ATPase/helicase domain would suggest an intrinsically unusual or poor immunogenicity for this protein. Additionally, no data to date suggest that the N-terminal protease domain interferes with the immunogenicity or antigenicity of the ATPase/helicase domain (M. Chen, M. S~illberg, A. Sonnerborg, L. Jin, A. Burkett, D. Peterson & D. R. Milich, unpublished results) . Therefore, the seemingly limited immunogenicity of HCV NS3 in humans may be secondary to low levels of NS3 protein expression during both acute and chronic phase HCV infections.
Interestingly, the majority (7/10) of the identified murine T cell sites coincide with a possibly dominant region for human Th cell recognition of NS3 spanning the residues 1207-1488 . Also, the identified H-2k-restricted NS3-specific T cell site at residues 1447-1462 completely overlapped a previously identified cytotoxic T cell (CTL) epitope recognized by a chimpanzee with chronic HCV infection (Erickson et al., 1993) . A recent paper from the same group suggested the emergence of a CTL escape mutation within this site (Weiner et al., 1995) .
Overall the human and murine immune responses to the NS3 ATPase/helicase domain are similar. Both species seem to develop antibodies which primarily recognize discontinuous or conformationally dependent determinants within HCV NS3. However, peptidic NS3-specific reactivities of a much lower magnitude can also be found in both hosts (Khudyakov eta]., 1995 ; Zhang et al., 1994) . This is in contrast to the human and murine serological responses to the HCV core and NS4 proteins in which reactivities directed towards linear determinants are frequently observed (Kakimi et al., 1995; Khudyakov et al., 1995; Simmonds et at., 1993; S~illberg et al., 1992 Zhang et al., 1995) . Also, with respect to the phenotype of the primed NS3-specific T cells, similarities can be found between mice and humans. Both the murine primary antibody response and the NS3-specific antibody response in chronically infected humans are restricted to a single IgG isotype (M. Chen, M. Sallberg, A. Sonnerborg, L. Jin, A. Burkett, D. Peterson & D. R. Milich, unpublished results) . Moreover, irrespective of the species and the MHC of the host, the phenotype of the NS3-specific T cell response seems to be biased towards IL-2 and IFN-~ production . Whether this has any significance to HCV infections remains to be determined. In mice the predominance of anti-NS3 IgG1 in the primary response (positively regulated by Th2 cytokines) and detection of mainly Th0/Thl cytokines in culture supernatants may seem inconsistent. This may, however, accurately reflect the nature of a polyclonal response, as indicated by the mixtures of IgG isotypes developed in the secondary response. We are currently studying this further.
The human and murine immune responses to the ATPase/ helicase domain of HCV NS3 show a number of similar characteristics. The presence of multiple NS3-derived MHC class II binding motifs explains the high frequency of NS3-specific antibody production in mice and may also serve to explain the high prevalence of anti-NS3 antibodies in HCVinfected immunocompetent humans.
